MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 172 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,894,000 | +75.2% | 107,579 | +72.8% | 0.39% | +177.3% |
Q4 2018 | $1,081,000 | -43.0% | 62,248 | -51.1% | 0.14% | -31.6% |
Q3 2018 | $1,897,000 | -33.5% | 127,333 | -29.1% | 0.21% | -15.9% |
Q2 2018 | $2,854,000 | +24.6% | 179,505 | +10.3% | 0.24% | +30.3% |
Q1 2018 | $2,291,000 | +58.8% | 162,778 | +57.9% | 0.19% | +229.8% |
Q4 2017 | $1,443,000 | +27.9% | 103,058 | +30.7% | 0.06% | -46.7% |
Q3 2017 | $1,128,000 | -5.5% | 78,877 | +4.0% | 0.11% | -0.9% |
Q2 2017 | $1,194,000 | +87.4% | 75,830 | +145.5% | 0.11% | +24.1% |
Q1 2016 | $637,000 | +154.8% | 30,894 | +153.1% | 0.09% | +22.5% |
Q4 2015 | $250,000 | +5.0% | 12,205 | -4.5% | 0.07% | -16.5% |
Q2 2015 | $238,000 | -62.6% | 12,785 | -66.9% | 0.08% | -68.0% |
Q4 2014 | $636,000 | -15.6% | 38,638 | -9.4% | 0.27% | -37.9% |
Q3 2014 | $754,000 | +57.1% | 42,639 | +93.7% | 0.43% | +81.4% |
Q1 2014 | $480,000 | – | 22,009 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |